Intermittent Subcutaneous Injections of Apomorphine in Parkinson’s Disease

Intermittent Subcutaneous Injections of Apomorphine in Parkinson’s Disease

Bibliographic Details
Main Authors:	Mustafa Ceylan, Murat Gültekin, Nazlı Durmaz Çelik, Bedia Samanci, Gül Yalçin Çakmakli, Rezzak Yilmaz
Format:	Article
Language:	English
Published:	Atatürk University 2022-12-01
Series:	Eurasian Journal of Medicine
Online Access:	https://www.eajm.org/en/intermittent-subcutaneous-injections-of-apomorphine-in-parkinson-s-disease-133438

Similar Items

Continuous subcutaneous apomorphine monotherapy in Parkinson’s disease
by: Ewa Papuć, et al.
Published: (2019-03-01)

Subcutaneous apomorphine in advanced Parkinson’s disease and its use in Indian population
by: Vinod Metta, et al.
Published: (2020-01-01)

Apomorphine in the Treatment of Parkinson’s Disease
by: Serhat Özkan
Published: (2021-12-01)

Apomorphine in Parkinson's disease—The questions raised
by: Rajinder K Dhamija, et al.
Published: (2020-01-01)

Ventricular Bigeminy after Subcutaneous Administration of Apomorphine in a Patient with Refractory Parkinson’s Disease: A Case Report
by: Anastasia N. Kaminioti, et al.
Published: (2013-05-01)

Continuous subcutaneous apomorphine infusion in the early phase of advanced Parkinson’s disease: A prospective study of 22 patients
by: Gustavo Fernández-Pajarín, et al.
Published: (2022-01-01)

Apomorphine in the treatment of Parkinson's disease: a review
by: Renata Ramina Pessoa, et al.

Akathisia in Parkinson's Disease: A Comperative Cross-sectional Study
by: Özlem Aykaç, et al.
Published: (2022-03-01)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
by: Angelo Antonini
Published: (2009-05-01)

Investigation of apomorphine during sleep in Parkinson’s: Improvement in UPDRS Scores
by: Miguel A. Pieroni
Published: (2019-12-01)

Challenges and trends in apomorphine drug delivery systems for the treatment of Parkinson's disease
by: Nrupa Borkar, et al.
Published: (2018-11-01)

Clinical trial evaluating apomorphine oromucosal solution in Parkinson's disease patients
by: Eva Thijssen, et al.
Published: (2024-05-01)

Apomorphine effects on the hippocampus
by: Luis Enrique Arroyo-Garcia, et al.
Published: (2018-01-01)

Evaluation of compliance and accuracy in Parkinson’s disease motor symptom tracking: a comparative study of digital and traditional paper diaries using a smartphone application (MyParkinson’s)
by: Nazli Durmaz Celik, et al.
Published: (2025-01-01)

Zonisamide Enhances Motor Effects of Levodopa, Not of Apomorphine, in a Rat Model of Parkinson’s Disease
by: Haruo Nishijima, et al.
Published: (2018-01-01)

Apomorphine Penject – Emerging Evidence and Treatment Strategies for Delayed on and off Periods in Parkinson’s disease
by: Olivier Rascol, et al.
Published: (2014-07-01)

Abnormal EEG Effects of Acute Apomorphine Injection in 5xFAD Transgenic Mice Are Partially Normalized in Those Chronically Pretreated with Apomorphine: The Time–Frequency Clustering of EEG Spectra
by: Vasily Vorobyov, et al.
Published: (2024-10-01)

The Use of Apomorphine in the PD SURG Trial
by: Rick, C, et al.
Published: (2010)

The Pharmacological Properties and Therapeutic Use of Apomorphine
by: Samo Ribarič
Published: (2012-05-01)

Looking beyond the fog—apomorphine demystified
by: L K Prashanth, et al.
Published: (2020-01-01)

Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine.
by: Jenkins, I, et al.
Published: (1992)

Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson's Disease
by: Andrew Thach, et al.
Published: (2021-11-01)

Long-term effect of apomorphine infusion in advanced Parkinson’s disease: a real-life study
by: Bruna Meira, et al.
Published: (2021-06-01)

Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson's Disease
by: Andrew Thach, et al.
Published: (2021-11-01)

AMITRIPTYLINE REDUCES THE GROWTH-HORMONE RESPONSE TO APOMORPHINE
by: Braddock, L, et al.
Published: (1984)

Apomorphine Suppresses the Progression of Steatohepatitis by Inhibiting Ferroptosis
by: Hiroshi Maeda, et al.
Published: (2024-07-01)

Apomorphine Targets the Pleiotropic Bacterial Regulator Hfq
by: Florian Turbant, et al.
Published: (2021-03-01)

Comparative Analysis of Cognitive Profiles of Huntington’s and Parkinson’s Diseases
by: Gül Yalçın Çakmaklı, et al.
Published: (2020-09-01)

The effect of amitriptyline treatment on the growth hormone response to apomorphine.
by: Cowen, P, et al.
Published: (1984)

Au nanoparticle-based sensor for apomorphine detection in plasma
by: Chiara Zanchi, et al.
Published: (2015-11-01)

The effects of Nicotine on licking behavior induced by Apomorphine in rats
by: MR Zarrindast, et al.
Published: (1999-10-01)

Effect of Dextromethorphan on Apomorphine induced licking behavior in rat
by: D Farzin, et al.
Published: (2005-10-01)

Safety and tolerability of long-term apomorphine infusion in advanced Parkinson's disease: an Indian multi-center (APO-IND) experience
by: Vinod Metta, et al.
Published: (2023-10-01)

Nistagmus Downbeat Nystagmus Due to Oxcarbazepine Intoxication
by: Gül Yalçın Çakmaklı, et al.
Published: (2009-09-01)

Prevention of medication errors in healthcare transition of patients treated with apomorphine
by: M. Ucha Sanmartin, et al.
Published: (2014-05-01)

Apomorphine is a potent inhibitor of ferroptosis independent of dopaminergic receptors
by: Akihiko Miyauchi, et al.
Published: (2024-02-01)

Apomorphine: The initial indian experience in relation to response tests and pumps
by: L K Prashanth, et al.
Published: (2020-01-01)

Relationship of Dopamine of the Nucleus Accumbens with Intra-infralimbic Apomorphine Microinjection
by: Abbas Alimoradian, et al.
Published: (2013-06-01)

Apomorphine titration with and without anti-emetic pretreatment in patients with Parkinson’s disease experiencing OFF episodes: A modified Delphi panel
by: Stuart H. Isaacson, et al.
Published: (2024-01-01)

Habenula volume change in Parkinson's disease: A 7T MRI study
by: Bedia Samanci, et al.
Published: (2024-09-01)